Pfizer: “Pfizer and BioNTech Announce Constructive Topline Outcomes From Pivotal Trial of COVID-19 Vaccine in Kids 5 to 11 Years.”
Enterprise Wire: “Pfizer and BioNTech Submit Preliminary Information to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Kids 5 to <12 Years of Age.”
MSNBC: “Fauci reacts to Pfizer information: We hopefully shall be vaccinating kids ‘by the top of October.’”
Gallup: “In U.S., 55% Would Get COVID-19 Vaccine for Younger Youngster.”
The New York Instances: “The F.D.A. once more warns dad and mom to not get kids below 12 vaccinated but.”
American Academy of Pediatrics: “AAP: Don’t use COVID-19 vaccine off-label for youngsters.”
Daybreak G., Missouri.
Carrie S., California.
Anne Liu, MD, medical affiliate professor, Division of Drugs, Division of Infectious Illnesses, and Division of Pediatrics, Division of Allergy, Immunology, and Rheumatology, Stanford College College of Drugs.
Michael Smith, MD, professor of pediatrics and member, Duke Human Vaccine Institute, Duke College College of Drugs.